$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Treatment of cancer with carcinostatic and immunostimulating agent containing lysophospholipid and phospholipid 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-031/685
  • A61K-045/05
출원번호 US-0125800 (1980-02-29)
우선권정보 JP-0024600 (1979-03-05); JP-0117262 (1979-09-14)
발명자 / 주소
  • Kodama Yutaka (Toyama JPX) Oyama Kaoru (Toyama JPX) Shimizu Ryusaku (Nanao JPX) Nakabayashi Masao (Namekawa JPX) Nakashima Yoshifumi (Himi JPX) Sano Takashi (Toyama JPX) Shibata Masaaki (Toyama JPX)
출원인 / 주소
  • Toyama Chemical Co., Ltd. (Tokyo JPX 03)
인용정보 피인용 횟수 : 72  인용 특허 : 1

초록 ▼

A carcinostatic and immunostimulating agent containing a lysophospholipid and a phospholipid. Said carcinostatic and immunostimulating agent is useful for the treatment of cancerous diseases of the mammals including human being. This disclosure concerns such a carcinostatic and immunostimulating age

대표청구항 ▼

A method for treating a host mammal having cancer, which comprises administering to said host mammal a therapeutically effective amount of a composition comprising a lysophospholipid and a phospholipid in an amount of 1 part by weight of lysophospholidpid to from 1.0-500 parts by weight of phospholi

이 특허에 인용된 특허 (1)

  1. Kny ; Gunter ; Westphal ; Otto, Glycerin-alkylether-(1)-phosphoric acid-(3)-monocholine esters as enhancers of the natural resistance of the mammalian.
    상세보기

이 특허를 인용한 특허 (72)

  1. Hrib Nicholas J. (Somerville NJ) Shoger Kirk D. (Piscataway NJ) Tegeler John J. (Bridgewater NJ), Alkoxycarbonylalkylphospholipids and alkylaminocarbonylalkylphospholipids.
    상세보기
  2. Hrib, Nicholas J.; Shoger, Kirk D.; Tegeler, John J., Alkoxycarbonylalkylphospholipids and alkylaminocarbonylalkylphospholipids.
    상세보기
  3. Urban Richard W. (Boulder CO), Biologic response modifier.
    상세보기
  4. Malinin, Vladimir, Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods of use thereof.
    상세보기
  5. Hasty Paul, Disruption of the mammalian Rad51 protein and disruption of proteins that associate with mammalian Rad51 for hindering cell proliferation.
    상세보기
  6. Janoff Andrew S. (Lawrenceville NJ) Alving Carl R. (Washington DC) Fountain Michael W. (Plainsboro NJ) Lenk Robert P. (Lambertville NJ) Ostro Marc J. (North Brunswick NJ) Popescu Mircea C. (Plainsbor, Drug preparations of reduced toxicity.
    상세보기
  7. Bally Marcel B.,CAX ; Cullis Pieter R.,CAX ; Hope Michael J.,CAX ; Madden Thomas D.,CAX ; Mayer Lawrence D.,CAX, Encapsulation of antineoplastic agents in liposomes.
    상세보기
  8. Drucker, Daniel J.; Crivici, Anna E.; Sumner-Smith, Martin, Glucagon-like peptide-2 analogs.
    상세보기
  9. Drucker, Daniel J; Crivici, Anna E.; Sumner-Smith, Martin, Glucagon-like peptide-2 analogs.
    상세보기
  10. Drucker, Daniel J; Crivici, Anna E.; Sumner-Smith, Martin, Glucagon-like peptide-2 analogs.
    상세보기
  11. Drucker, Daniel J., Glucagon-like peptide-2 and its therapeutic use.
    상세보기
  12. Brachwitz Hans (c/o Academy of Sciences ; Otto-Nuschke-Strasse 22/23 D-x 1086 Berlin DDX) Langen Peter (c/o Academy of Sciences ; Otto-Nuschke-Strasse 22/23 D-x 1086 Berlin DDX) Lehmann Christine (c/, Glycero-3(2)-phospho-L-serine derivatives and salts thereof.
    상세보기
  13. Li, Zhili; Boni, Lawrence T.; Miller, Brian S.; Malinin, Vladimir; Li, Xingong, High delivery rates for lipid based drug formulations, and methods of treatment thereof.
    상세보기
  14. Mayer Lawrence D. (Vancouver CAX) Bally Marcel B. (Vancouver CAX) Cullis Pieter R. (Vancouver CAX) Ginsberg Richard S. (Jamesburg NJ) Mitilenes George N. (Washington NJ), High drug:lipid formulations of liposomal antineoplastic agents.
    상세보기
  15. Mayer Lawrence D.,CAX ; Bally Marcel B.,CAX ; Cullis Pieter R.,CAX ; Ginsberg Richard S. ; Mitilenes George N., High drug:lipid formulations of liposomal-antineoplastic agents.
    상세보기
  16. Tegeler John J. (Bridgewater NJ) Shoger Kirk D. (Minneapolis MN), Hydroxy-, alkoxy- and benzyloxy-substituted phospholipids.
    상세보기
  17. Rang, Romeo G.; Percheson, Paul B., Immunomodulating compositions for treatment of immune system disorders.
    상세보기
  18. Rang Romeo,ROX, Immunomodulating compositions from bile.
    상세보기
  19. Rang, Romeo, Immunomodulating compositions from bile.
    상세보기
  20. Steffen Hans (Arisdorf CHX) Ferro Alberto (Riehen CHX), Injectable solutions.
    상세보기
  21. Drucker Daniel J.,CAX ; Crivici Anna E. ; Sumner-Smith Martin,CAX, Intestinotrophic glucagon-like peptide-2 analogs.
    상세보기
  22. Conneely Orla M. ; Ward Pauline P., Lactoferrin variants and uses thereof.
    상세보기
  23. Shinitzky Meir (Rehovot ILX) Heron David (Tel Aviv ILX) Samuel David (Rehovot ILX), Lipid fraction for treating disease.
    상세보기
  24. Speiser Peter (Zurich CHX), Lipid nano-pellets as excipient system for perorally administered drugs.
    상세보기
  25. Weers, Jeff, Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof.
    상세보기
  26. Weers, Jeff, Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof.
    상세보기
  27. Weers, Jeff, Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof.
    상세보기
  28. Weers, Jeff, Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof.
    상세보기
  29. Weers, Jeff, Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof.
    상세보기
  30. Weers, Jeff, Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof.
    상세보기
  31. Weers, Jeff, Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof.
    상세보기
  32. Weers, Jeff, Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof.
    상세보기
  33. Weers, Jeff, Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof.
    상세보기
  34. Weers, Jeff, Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof.
    상세보기
  35. Mayhew Eric (South Wales NY) Ehrke M. Jane (Lancaster NY) Mace Kenneth (Buffalo NY) Szoka Francis (San Francisco CA) Olson Fred C. (Helena MT), Liposome drug delivery method and composition.
    상세보기
  36. Janoff Andrew S. (Yardley PA) Boni Lawrence (Monmouth Junction NJ) Madden Thomas D. (Vancouver CAX) Cullis Pieter R. (Vancouver CAX) Lenk Robert P. (Lambertville NJ) Kearns John J. (Princeton NJ) Dur, Low toxicity drug-lipid systems.
    상세보기
  37. Nishikawa Kohei (Kyoto JPX) Tsushima Susumu (Suita JPX) Nomura Hiroaki (Takatsuki JPX), Method for inhibiting activities of platelet activating factor.
    상세보기
  38. Adamich Marina (Boothwyn PA) Bach David T. (Wilmington DE), Method for manufacturing liposomes.
    상세보기
  39. Gupta, Renu, Method for treating pulmonary disorders with liposomal amikacin formulations.
    상세보기
  40. Pruss Thaddeus P., Method for treating viral infection.
    상세보기
  41. Gersonde Klaus (Preusweg 69 D-5100 Aachen DEX) Schl Wilfried (Tannenwaldweg 27 D-6380 ; Bad Homburg DEX), Method of and arrangement for producing lipid vesicles.
    상세보기
  42. Gupta, Renu, Method of treating pulmonary disorders with liposomal amikacin formulations.
    상세보기
  43. Gupta, Renu, Method of treating pulmonary disorders with liposomal amikacin formulations.
    상세보기
  44. Eagle, Gina; Gupta, Renu, Methods for treating pulmonary non-tuberculous mycobacterial infections.
    상세보기
  45. Eagle, Gina; Gupta, Renu, Methods for treating pulmonary non-tuberculous mycobacterial infections.
    상세보기
  46. Eagle, Gina; Gupta, Renu, Methods for treating pulmonary non-tuberculous mycobacterial infections.
    상세보기
  47. Drucker Daniel J.,CAX, Methods of enhancing functioning of the large intestine.
    상세보기
  48. Drucker, Daniel J., Methods of enhancing functioning of the large intestine.
    상세보기
  49. Drucker, Daniel J., Methods of enhancing functioning of the large intestine.
    상세보기
  50. Drucker, Daniel J., Methods of enhancing functioning of the large intestine.
    상세보기
  51. Andrew S. Janoff ; Thomas D. Madden CA; Pieter R. Cullis CA; John J. Kearns ; Anthony G. Durning, Methods of preparing low-toxicity drug-lipid complexes.
    상세보기
  52. Gupta, Renu, Methods of treating pulmonary disorders with liposomal amikacin formulations.
    상세보기
  53. Gupta, Renu, Methods of treating pulmonary disorders with liposomal amikacin formulations.
    상세보기
  54. Gupta, Renu, Methods of treating pulmonary disorders with liposomal amikacin formulations.
    상세보기
  55. Mayer Lawrence D.,CAX ; Bally Marcel B.,CAX ; Cullis Pieter R.,CAX ; Ginsberg Richard S. ; Mitilenes George N., Methods of treatment using high drug-lipid formulations of liposomal-antineoplastic agents.
    상세보기
  56. Nair Haridasan K. (Madison WI), N-het-substituted glycerophosphoethanolamines.
    상세보기
  57. Baschang Gerhard (Bettingen CHX) Fechtig Bruno (Reinach CHX) Hartmann Albert (Grenzach DEX) Lukas Bohumir (Basel CHX) Wacker Oskar (Basel CHX), Phosphatidyl compounds, processes for their manufacture, and their use.
    상세보기
  58. Bosies Elmar (Weinheim DEX) Gall Rudi (Hirschberg DEX) Weimann Gnter (Weinheim-Ltzelsachsen DEX) Bicker Uwe (Lorsch DEX) Pahlke Wulf (Mannheim DEX), Phospholipid compound.
    상세보기
  59. Nojima Shoshichi (Tokyo JPX) Nomura Hiroaki (Osaka JPX) Tsushima Susumu (Osaka JPX), Phospholipids.
    상세보기
  60. Gossioux Pierre,FRX, Polar lipid composition of plant origin.
    상세보기
  61. Fechtig Bruno (Reinach CHX) Baschang Gerhard (Bettingen CHX), Saccharide derivatives and processes for their manufacture.
    상세보기
  62. Tilcock Colin P. S. (Vancouver CAX) Cullis Pieter R. (Vancouver CAX) Hope Michael J. (Vancouver PA CAX) Janoff Andrew S. (Yardley PA), Solubilization of hydrophobic materials using lysophospholipid.
    상세보기
  63. Perkins, Walter; Malinin, Vladimir, Stabilized vancomycin formulations.
    상세보기
  64. Reszka Regina (Schwanebeck DEX) Fichtner Iduna (Berlin DEX), Stimulating hematopoietic activity with carboplatin or lobaplatin.
    상세보기
  65. Boni, Lawrence T.; Miller, Brian S., Sustained release of antiinfectives.
    상세보기
  66. Boni, Lawrence T.; Miller, Brian S.; Malinin, Vladimir; Li, Xingong, Sustained release of antiinfectives.
    상세보기
  67. Boni, Lawrence T.; Miller, Brian S.; Malinin, Vladimir; Li, Xingong, Sustained release of antiinfectives.
    상세보기
  68. Boni, Lawrence T.; Miller, Brian S.; Malinin, Vladimir; Li, Xingong, Sustained release of antiinfectives.
    상세보기
  69. Perkins, Walter; Malinin, Vladimir; Li, Xingong; Miller, Brian; Seidel, Dominique; Holzmann, Philipp; Schulz, Harald; Hahn, Michael, Systems for treating pulmonary infections.
    상세보기
  70. Luck Edward E. (Menlo Park CA) Brown Dennis M. (Menlo Park CA), Treatments employing vasoconstrictive substances in combination with cytotoxic agents for introduction into cellular les.
    상세보기
  71. Roberts Mary P. (Newton MA) Gabriel Nancy E. (Wellesley MA), Unilamellar lipid vesicles and method for their formation.
    상세보기
  72. Fukushima Tsunekazu (Hyogo JPX) Emoto Hiroshi (Osaka JPX) Kagitani Yoshio (Nara JPX) Yokoyama Kazumasa (Osaka JPX) Nishida Masayuki (Osaka JPX) Suyama Tadakazu (Kyoto JPX), Water soluble drug complex and method for production of same.
    상세보기

관련 콘텐츠

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로